Home / Health / Cancer Drug Prices Slashed Up to 93%!
Cancer Drug Prices Slashed Up to 93%!
6 Nov
Summary
- Trade margins capped at 30% for 137 anti-cancer drugs.
- Nearly 900 cancer medicine brands see price reduction.
- Price regulation may not guarantee comprehensive cancer care.
The National Pharmaceutical Pricing Authority (NPPA) in India has implemented a significant policy change by capping trade margins at 30% for 137 non-scheduled anti-cancer drugs. This regulatory action is expected to substantially reduce the cost of nearly 900 cancer medicine brands.
Prices for these essential cancer treatments could decrease by as much as 70% to 93%. This initiative aims to alleviate the financial burden on patients seeking cancer therapy.
Despite the substantial price reductions, a critical question arises about the overall affordability and accessibility of comprehensive cancer care in India. Experts suggest that price regulation alone may not be sufficient to address all challenges in cancer treatment.
